Fang, Hong MD*; Chuang, Hubert H. MD†; Strati, Paolo MD‡,§; Hu, Shimin MD, PhD*; Shuai, Wen MD*; Medeiros, L. Jeffrey MD*; Wang, Wei MD, PhD*
Departments of *Hematopathology
†Nuclear Medicine
‡Lymphoma and Myeloma
§Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
W.W. and L.J.M.: designed the study. H.F.: wrote the manuscript. H.H.C., P.S., S.H., and W.S.: collected data and performed analysis.
Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Wei Wang, MD, PhD, Department of Hematopathology, Unit 72, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 (e-mail: [email protected]).
doi: 10.1097/PAS.0000000000001547